TrademarkOpen
Search / United States / 97463189

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

ENVECSI

Allowed — statement of use stage
Fifth Extension - Granted
Used for: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory…
Show more

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 21 Jun 2022
    Application filed
    New Application Entered
  2. 29 Mar 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 29 Mar 2023
    Office action issued
    Non-Final Action Written
  4. 1 Jun 2023
    Response to office action filed
    Teas Response To Office Action Received
  5. 29 Jun 2023
    Approved for publication
    Approved For Pub - Principal Register
  6. 8 Aug 2023
    Published for opposition
    Published For Opposition
  7. 3 Oct 2023
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 20 Mar 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 26 Sep 2024
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 27 Mar 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 35 events
2026-08-04Notice Of Approval Of Extension Request E-Mailed
2026-08-03Case Assigned To Intent To Use Paralegal
2026-08-03Sou Extension 5 Granted
2026-03-31Sou Teas Extension Received
2026-03-30Sou Extension 5 Filed
2025-09-18Sou Teas Extension Received
2025-09-18Sou Extension 4 Filed
2025-09-18Sou Extension 4 Granted
2025-09-18Notice Of Approval Of Extension Request E-Mailed
2025-03-28Notice Of Approval Of Extension Request E-Mailed
2025-03-27Sou Teas Extension Received
2025-03-27Sou Extension 3 Filed
2025-03-27Sou Extension 3 Granted
2024-09-26Sou Teas Extension Received
2024-09-26Sou Extension 2 Filed
2024-09-26Sou Extension 2 Granted
2024-09-26Notice Of Approval Of Extension Request E-Mailed
2024-03-21Notice Of Approval Of Extension Request E-Mailed
2024-03-20Sou Teas Extension Received
2024-03-20Sou Extension 1 Filed
2024-03-20Sou Extension 1 Granted
2023-10-03Noa Mailed - Sou Required From Applicant
2023-08-08Published For Opposition
2023-08-08Official Gazette Publication Confirmation E-Mailed
2023-07-19Notification Of Notice Of Publication E-Mailed
2023-06-29Approved For Pub - Principal Register
2023-06-01Teas Response To Office Action Received
2023-06-01Correspondence Received In Law Office
2023-06-01Teas/Email Correspondence Entered
2023-03-29Assigned To Examiner
2023-03-29Non-Final Action Written
2023-03-29Non-Final Action E-Mailed
2023-03-29Notification Of Non-Final Action E-Mailed
2022-07-05New Application Office Supplied Data Entered
2022-06-21New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; anti-allergics; vaccines

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 4 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.